Bausch + Lomb Corp (BLCO.TO) is facing a notable decline, shedding 2.81% in today's trading session.
The stock of Bausch + Lomb Corp has dropped 2.81% today, closing at CA$23.86. This decline reflects ongoing investor concerns about the company's financial health and market position, particularly in light of recent earnings reports and market forecasts.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Bausch + Lomb Corp
BLCO.TO
BLCO.TO
Bausch + Lomb Corp
WealthAwesomeMarket cap
$8.09B
52W high
$25.70
52W low
$18.24
1W change
-3.75%
Beta
0.56
Analyst Price Targets
Based on analyst covering BLCO
Wall Street analysts forecast BLCO stock price to fall 15.0% over the next 12 months.
Consensus
Moderately BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$18.79
-15.0% Upside
Current Price
C$22.10
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BLCO's historical volatility
30-Day Vol
34.4%
Annualized
90-Day Vol
30.7%
Annualized
Trend (90d)
+11.0%
Annualized drift
90d Mean
C$22.98
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$22.39 | C$19.88 โ C$25.22 |
| 60 trading days | C$22.69 | C$19.18 โ C$26.84 |
| 90 trading days | C$22.98 | C$18.71 โ C$28.24 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious with Bausch + Lomb as it navigates a challenging landscape marked by falling earnings and increased capital intensity.
Bausch + Lomb Corp's stock drops 2.81% today.
The company's market cap stands at CA$8.75 billion, but its profit margin is currently negative at -4.21%, highlighting financial challenges.
Bull case
Despite today's decline, Bausch + Lomb has a long history in eye care and continues to innovate its product offerings. This innovation could help the company recover if market conditions improve.
Bear case
However, the company's declining earnings per share and free cash flow margin raise concerns about its ability to achieve sustainable growth, making it a risky investment.
Market Reaction
Investors reacted negatively to Bausch + Lomb's recent performance metrics, which showed a troubling trend in earnings per share. The stock's drop today reflects broader skepticism about the company's ability to maintain its market position amidst increasing competition and operational challenges.
Financial Health Concerns
Bausch + Lomb's profit margin has turned negative, and its free cash flow has declined significantly over the past five years. These financial indicators suggest that the company may struggle to invest in growth opportunities, making it a less attractive option for risk-averse investors.
Outlook and Future Considerations
While Bausch + Lomb has a strong legacy in eye health, the current market dynamics present challenges that could hinder its growth. Investors should keep an eye on upcoming earnings reports and market analyses to gauge whether the stock can rebound or if further declines are on the horizon. For a deeper dive into Bausch + Lomb's performance, check out our detailed analysis on BLCO.TO.
Advertisement
